NMI-221

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameNMI-221
Drug Alias NameMoxisylyte-SNOS-Nitrosylated moxisylyteSNO-moxisylyte
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha adrenergic receptor antagonistsNitric oxide donors
TargetsAlpha adrenergic receptor
Therapy Area/IndicationsErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNitromed Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBoston University School of MedicineNitromed Inc
Active IndicationsN/A
Inactive IndicationsErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A